e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Phenotypes contribute to treatments
Yingmeng Ni, Guochao Shi
Source:
Eur Respir J, 49 (5) 1700054; 10.1183/13993003.00054-2017
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yingmeng Ni, Guochao Shi. Phenotypes contribute to treatments. Eur Respir J, 49 (5) 1700054; 10.1183/13993003.00054-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Phenotypes and endotypes
Source: Eur Respir Monogr 2018; 81: 133-152
Year: 2018
Genes, mechanisms and new therapies for asthma
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Factors that affect the treatment of patients with asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
Phenotypes and prognosis
Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Year: 2019
Associations between genetic polymorphisms and drug response phenotypes in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
Underlying mechanisms and pharmacological approaches for treatment of sarcopenia
Source: Virtual Congress 2021 – Sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options
Year: 2021
Physiological phenotypes
Source: Eur Respir Monogr 2015; 67: 9-23
Year: 2015
Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutations
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019
Combination therapy of ICSs/LABAs plus montelucastin patients with severe asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Effects of formoterol on the molecular mechanisms of corticosteroid resistance in models with high oxidative stress
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Genetic and environmental influences on different asthma phenotypes
Source: Eur Respir J 2002; 20: Suppl. 38, 426s
Year: 2002
When and how to identify resistance mechanisms to targeted therapies
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019
Phenotypes in difficult to treat asthma
Source: Annual Congress 2009 - Phenotype-driven asthma treatment in children
Year: 2009
COPD phenotypes and co-morbidities: to what extent do they affect a successful response to rehabilitation?
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011
Features of FeNO-high asthma phenotype
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Linking phenotypes to personalised treatments in asthma and COPD
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021
Markers of cell proliferation contributes to the therapeutic effect of growth factor-LGF on experimental emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Rare genetic variants in genes with ciliary function underlie non-smoking related COPD
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
Polymorphisms in CCR5 confer susceptibility to Löfgren‘s syndrome and may regulate the immune response
Source: Annual Congress 2011 - Biomarkers in sarcoidosis
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept